VCEL
Price
$43.07
Change
-$1.55 (-3.47%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
2.16B
35 days until earnings call
VCYT
Price
$29.56
Change
-$0.09 (-0.30%)
Updated
Apr 1 closing price
Capitalization
1.66B
41 days until earnings call
Ad is loading...

VCEL vs VCYT

Header iconVCEL vs VCYT Comparison
Open Charts VCEL vs VCYTBanner chart's image
Vericel
Price$43.07
Change-$1.55 (-3.47%)
Volume$4.47K
Capitalization2.16B
Veracyte
Price$29.56
Change-$0.09 (-0.30%)
Volume$684.56K
Capitalization1.66B
VCEL vs VCYT Comparison Chart
Loading...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VCEL vs. VCYT commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VCEL is a Buy and VCYT is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (VCEL: $44.62 vs. VCYT: $29.65)
Brand notoriety: VCEL and VCYT are both not notable
VCEL represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: VCEL: 115% vs. VCYT: 112%
Market capitalization -- VCEL: $2.16B vs. VCYT: $1.66B
VCEL [@Biotechnology] is valued at $2.16B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VCEL’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • VCEL’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, both VCEL and VCYT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VCEL’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • VCEL’s TA Score: 5 bullish, 3 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VCEL is a better buy in the short-term than VCYT.

Price Growth

VCEL (@Biotechnology) experienced а -6.93% price change this week, while VCYT (@Medical Specialties) price change was -10.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.35%. For the same industry, the average monthly price growth was +2.11%, and the average quarterly price growth was +3.08%.

Reported Earning Dates

VCEL is expected to report earnings on May 07, 2025.

VCYT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-3.35% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($2.16B) has a higher market cap than VCYT($1.66B). VCEL YTD gains are higher at: -18.740 vs. VCYT (-25.126). VCEL has higher annual earnings (EBITDA): 16.6M vs. VCYT (-49.41M). VCYT has more cash in the bank: 216M vs. VCEL (116M). VCYT has less debt than VCEL: VCYT (12.6M) vs VCEL (98.8M). VCYT has higher revenues than VCEL: VCYT (361M) vs VCEL (237M).
VCELVCYTVCEL / VCYT
Capitalization2.16B1.66B130%
EBITDA16.6M-49.41M-34%
Gain YTD-18.740-25.12675%
P/E Ratio215.43N/A-
Revenue237M361M66%
Total Cash116M216M54%
Total Debt98.8M12.6M784%
FUNDAMENTALS RATINGS
VCEL vs VCYT: Fundamental Ratings
VCEL
VCYT
OUTLOOK RATING
1..100
687
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
5189
SMR RATING
1..100
8588
PRICE GROWTH RATING
1..100
6362
P/E GROWTH RATING
1..100
10059
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (82) in the Biotechnology industry is in the same range as VCEL (90) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to VCEL’s over the last 12 months.

VCEL's Profit vs Risk Rating (51) in the Medical Specialties industry is somewhat better than the same rating for VCYT (89) in the Biotechnology industry. This means that VCEL’s stock grew somewhat faster than VCYT’s over the last 12 months.

VCEL's SMR Rating (85) in the Medical Specialties industry is in the same range as VCYT (88) in the Biotechnology industry. This means that VCEL’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's Price Growth Rating (62) in the Biotechnology industry is in the same range as VCEL (63) in the Medical Specialties industry. This means that VCYT’s stock grew similarly to VCEL’s over the last 12 months.

VCYT's P/E Growth Rating (59) in the Biotechnology industry is somewhat better than the same rating for VCEL (100) in the Medical Specialties industry. This means that VCYT’s stock grew somewhat faster than VCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VCELVCYT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
71%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FESGX68.280.08
+0.12%
First Eagle Global C
GSICX25.73N/A
N/A
Goldman Sachs International Eq ESG C
SCQGX78.54N/A
N/A
DWS Large Cap Focus Growth S
NSMRX31.39N/A
N/A
Nuveen Small/Mid-Cap Value I
ASPZX27.02N/A
N/A
Alger Spectra Z

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+0.27%
VCYT - VCEL
52%
Loosely correlated
-1.56%
BEAM - VCEL
41%
Loosely correlated
-12.07%
AXON - VCEL
38%
Loosely correlated
-1.68%
NUVB - VCEL
37%
Loosely correlated
-3.30%
KRYS - VCEL
37%
Loosely correlated
-1.97%
More